Stockreport
How Luciana Preger Is Helping Advance Gilead's Work in Oncology [Yahoo! Finance]
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Luciana is a physician with more than 20 years of experience in pharma and she came to Gilead to help transform treatments for people living with cancer. "As a child, I loved the opportunity to go on rounds with my father at the hospital in Rio de Janeiro and witness the bedside connections he made with patients," says Luciana, Vice President, Global Medical Affairs, Oncology. "To this day, I carry with me the emotion that I saw on those rounds at a young age. I don't want to ever forget that." Improving outcomes and access to medicine for people living with disease drives her work. In fact, it was Gilead's legacy of expanding global access to life-changing medicines that first attracted Luciana to the company, as she longed to be in an environment where she could play a bigger role in bridging the gap between scientific innovation and patient care. "To truly transform the way cancer is treated, oncology advances must be built on a foundation of equitable care," she says. "There
[Read more]
IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- Gilead Sciences stock jumps on HIV treatment trial success [Yahoo! Finance Canada][Yahoo! Finance Canada]
- Gilead Stock Surges on Strong Results in HIV Drug Study [Yahoo! Finance][Yahoo! Finance]
- Nvidia Reverses Lower From New High; Is The Stock A Buy Now? [Yahoo! Finance][Yahoo! Finance]
- Gilead Sciences, Inc. (NASDAQ: GILD) had its "neutral" rating re-affirmed by analysts at Robert W. Baird. They now have a $80.00 price target on the stock.[MarketBeat]
- Gilead's Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for HIV Prevention [Yahoo! Finance][Yahoo! Finance]
- More
GILD
SEC Filings
SEC Filings
- 6/11/24 - Form 4
- 6/11/24 - Form 4
- 6/11/24 - Form 4
- GILD's page on the SEC website
- More